Simultaneous targeting therapy for lung metastasis and breast tumor by blocking the NF-κB signaling pathway using Celastrol-loaded micelles.

Simultaneous targeting therapy for lung metastasis and breast tumor by blocking the NF-κB signaling pathway using Celastrol-loaded micelles.
复制标题

使用雷公藤红胶束阻断 NF-κ B 信号通路同时靶向治疗肺转移和乳腺肿瘤

DOI:
10.1080/10717544.2018.1425778
复制
发表时间:
2018-11
期刊:
影响因子:
6
通讯作者:
Hu F
Hu F
中科院分区:
医学2区
文献类型:
--
作者:
Zhao Y;Tan Y;Meng T;Liu X;Zhu Y;Hong Y;Yang X;Yuan H;Huang X;Hu F

文献摘要

参考文献

被引文献

相似文献

转移是乳腺肿瘤治疗成功的主要障碍之一。为了同时抑制乳腺肿瘤的转移和生长,建立了αvβ3配体四碘甲腺乙酸(泰特)修饰的南蛇藤酚(Cela)负载糖脂样缀合物(CSOSA/Cela)(TET-CSOSA/Cela),以阻断核因子-kappa B(NF-κB)信号通路。TET-CSOSA通过αvβ3受体介导的相互作用,在4 T1荷瘤小鼠肺转移瘤和原发瘤中的分布明显增加。结果表明TET-CSOSA/Cela通过阻断NF-κB,显著抑制肺转移瘤细胞Bcl-2的活化和4 T1乳腺癌细胞MMP-9的表达。TET-CSOSA/Cela对肺转移瘤和原发瘤的抑制率分别为90.72%和81.15%,而雷公藤红素的抑制率分别为72.15%和46.40%。结果表明,以αvβ3受体为靶点的TET-CSOSA/Cela胶束通过阻断NF-κB信号通路,具有同时治疗肺转移瘤和原发性肿瘤的潜力。
Metastasis is one of the major obstacles for successful therapy of breast tumor. To inhibit the metastasis and growth of breast tumor simultaneously, a Celastrol (Cela) loaded glucolipid-like conjugates (CSOSA/Cela) with αvβ3-ligand Tetraiodothyroacetic acid (TET) modification (TET-CSOSA/Cela) were established to block nuclear factor-kappa B (NF-κB) signaling pathway. The distribution of TET-CSOSA was remarkably increased in lung metastasis and primary tumor of 4T1 tumor-bearing mice by means of αvβ3 receptor-mediated interaction. The results demonstrated that TET-CSOSA/Cela significantly suppressed Bcl-2 activation of lung metastatic cells and reduced MMP-9 expression of 4T1 breast tumor cells by blocking NF-κB. The inhibitory rates of TET-CSOSA/Cela against lung metastasis and primary tumor were raised to 90.72 and 81.15%, compared to those of Celastrol (72.15 and 46.40%), respectively. All results demonstrated the αvβ3 receptor targeted TET-CSOSA/Cela micelles exhibited great potential in treating lung metastasis and primary tumor simultaneously via blocking NF-κB signaling pathway.
DOI: 10.1158/0008-5472.can-09-0755
发表时间: 2009-07-15
期刊: Cancer research
影响因子: 11.2
作者:
Pang X;Yi Z;Zhang X;Sung B;Qu W;Lian X;Aggarwal BB;Liu M
通讯作者: Liu M
DOI: 10.1155/2013/281230
发表时间: 2013
影响因子: --
作者:
Ahmed M;Douek M
通讯作者: Douek M
DOI: 10.1038/nrc2627
发表时间: 2009-04-01
影响因子: 78.5
作者:
Klein, Christoph A.
通讯作者: Klein, Christoph A.
DOI: 10.1038/nm1519
发表时间: 2007-01-01
期刊: NATURE MEDICINE
影响因子: 82.9
作者:
Park, Bae Keun;Zhang, Honglai;Wang, Cun-Yu
通讯作者: Wang, Cun-Yu
DOI: 10.1007/s10456-008-9110-8
发表时间: 2008-09-01
期刊: ANGIOGENESIS
影响因子: 9.8
作者:
Rebbaa, Abdelhadi;Chu, Fei;Mousa, Shaker A.
通讯作者: Mousa, Shaker A.